Lecithin-bound superoxide dismutase in the treatment of noninfectious corneal ulcers

Shigeto Shimmura, Rie Igarashi, Hiromoto Yaguchi, Yoshie Ohashi, Jun Shimazaki, Kazuo Tsubota

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

PURPOSE: To evaluate the effects of a lipophilic analog of superoxide dismutase in the treatment of persistent epithelial defects of the cornea. DESIGN: Interventional case series. METHODS: Nineteen eyes of 19 patients with noninfectious corneal ulcers were enrolled. Patient profiles consisted of seven cases with Mooren-type peripheral ulcers, three cases with chemical or thermal burns, two cases with vernal keratoconjunctivitis, four cases with cicatricial keratoconjunctivitis, and three cases with sterile ulcers after corneal surgery. Patients consisted of 11 men and 8 women, with a mean age of 51.5 ± 17.9 years (range, 14-77). Only patients who did not respond to conventional therapy were recruited for the study. Lecithinated superoxide dismutase was applied for 2 weeks, and sketches and/or fluorescein slit micrographs were recorded before and at the end of the study. The main outcome measure was decrease in ulcer size. RESULTS: As a group, the average ulcer size relative to the entire cornea decreased from 18.2 ± 15.1% to 10.0 ± 15.0% after 2 weeks (P < .05). A dramatic effect (>90% decrease in ulcer size) was observed in eight cases (100% in six cases), whereas no apparent change was found (<30% decrease in ulcer size) in five cases. The presence of polymorphonucleocytes within the ulcerated tissue was confirmed by brush cytology. CONCLUSION: Lecinthinated superoxide dismutase was effective in decreasing persistent epithelial defect size in a subset of patients with sterile corneal ulcers refractive to conventional therapy. A large-scale clinical investigation is merited.

Original languageEnglish
Pages (from-to)613-619
Number of pages7
JournalAmerican Journal of Ophthalmology
Volume135
Issue number5
DOIs
Publication statusPublished - 2003 May 1
Externally publishedYes

Fingerprint

Corneal Ulcer
Lecithins
Superoxide Dismutase
Ulcer
Cornea
Keratoconjunctivitis
Allergic Conjunctivitis
Therapeutics
Fluorescein
Burns
Cell Biology
Hot Temperature
Outcome Assessment (Health Care)

ASJC Scopus subject areas

  • Ophthalmology

Cite this

Lecithin-bound superoxide dismutase in the treatment of noninfectious corneal ulcers. / Shimmura, Shigeto; Igarashi, Rie; Yaguchi, Hiromoto; Ohashi, Yoshie; Shimazaki, Jun; Tsubota, Kazuo.

In: American Journal of Ophthalmology, Vol. 135, No. 5, 01.05.2003, p. 613-619.

Research output: Contribution to journalArticle

Shimmura, Shigeto ; Igarashi, Rie ; Yaguchi, Hiromoto ; Ohashi, Yoshie ; Shimazaki, Jun ; Tsubota, Kazuo. / Lecithin-bound superoxide dismutase in the treatment of noninfectious corneal ulcers. In: American Journal of Ophthalmology. 2003 ; Vol. 135, No. 5. pp. 613-619.
@article{48f1494473344b70ae573994384f3ad3,
title = "Lecithin-bound superoxide dismutase in the treatment of noninfectious corneal ulcers",
abstract = "PURPOSE: To evaluate the effects of a lipophilic analog of superoxide dismutase in the treatment of persistent epithelial defects of the cornea. DESIGN: Interventional case series. METHODS: Nineteen eyes of 19 patients with noninfectious corneal ulcers were enrolled. Patient profiles consisted of seven cases with Mooren-type peripheral ulcers, three cases with chemical or thermal burns, two cases with vernal keratoconjunctivitis, four cases with cicatricial keratoconjunctivitis, and three cases with sterile ulcers after corneal surgery. Patients consisted of 11 men and 8 women, with a mean age of 51.5 ± 17.9 years (range, 14-77). Only patients who did not respond to conventional therapy were recruited for the study. Lecithinated superoxide dismutase was applied for 2 weeks, and sketches and/or fluorescein slit micrographs were recorded before and at the end of the study. The main outcome measure was decrease in ulcer size. RESULTS: As a group, the average ulcer size relative to the entire cornea decreased from 18.2 ± 15.1{\%} to 10.0 ± 15.0{\%} after 2 weeks (P < .05). A dramatic effect (>90{\%} decrease in ulcer size) was observed in eight cases (100{\%} in six cases), whereas no apparent change was found (<30{\%} decrease in ulcer size) in five cases. The presence of polymorphonucleocytes within the ulcerated tissue was confirmed by brush cytology. CONCLUSION: Lecinthinated superoxide dismutase was effective in decreasing persistent epithelial defect size in a subset of patients with sterile corneal ulcers refractive to conventional therapy. A large-scale clinical investigation is merited.",
author = "Shigeto Shimmura and Rie Igarashi and Hiromoto Yaguchi and Yoshie Ohashi and Jun Shimazaki and Kazuo Tsubota",
year = "2003",
month = "5",
day = "1",
doi = "10.1016/S0002-9394(02)02151-7",
language = "English",
volume = "135",
pages = "613--619",
journal = "American Journal of Ophthalmology",
issn = "0002-9394",
publisher = "Elsevier USA",
number = "5",

}

TY - JOUR

T1 - Lecithin-bound superoxide dismutase in the treatment of noninfectious corneal ulcers

AU - Shimmura, Shigeto

AU - Igarashi, Rie

AU - Yaguchi, Hiromoto

AU - Ohashi, Yoshie

AU - Shimazaki, Jun

AU - Tsubota, Kazuo

PY - 2003/5/1

Y1 - 2003/5/1

N2 - PURPOSE: To evaluate the effects of a lipophilic analog of superoxide dismutase in the treatment of persistent epithelial defects of the cornea. DESIGN: Interventional case series. METHODS: Nineteen eyes of 19 patients with noninfectious corneal ulcers were enrolled. Patient profiles consisted of seven cases with Mooren-type peripheral ulcers, three cases with chemical or thermal burns, two cases with vernal keratoconjunctivitis, four cases with cicatricial keratoconjunctivitis, and three cases with sterile ulcers after corneal surgery. Patients consisted of 11 men and 8 women, with a mean age of 51.5 ± 17.9 years (range, 14-77). Only patients who did not respond to conventional therapy were recruited for the study. Lecithinated superoxide dismutase was applied for 2 weeks, and sketches and/or fluorescein slit micrographs were recorded before and at the end of the study. The main outcome measure was decrease in ulcer size. RESULTS: As a group, the average ulcer size relative to the entire cornea decreased from 18.2 ± 15.1% to 10.0 ± 15.0% after 2 weeks (P < .05). A dramatic effect (>90% decrease in ulcer size) was observed in eight cases (100% in six cases), whereas no apparent change was found (<30% decrease in ulcer size) in five cases. The presence of polymorphonucleocytes within the ulcerated tissue was confirmed by brush cytology. CONCLUSION: Lecinthinated superoxide dismutase was effective in decreasing persistent epithelial defect size in a subset of patients with sterile corneal ulcers refractive to conventional therapy. A large-scale clinical investigation is merited.

AB - PURPOSE: To evaluate the effects of a lipophilic analog of superoxide dismutase in the treatment of persistent epithelial defects of the cornea. DESIGN: Interventional case series. METHODS: Nineteen eyes of 19 patients with noninfectious corneal ulcers were enrolled. Patient profiles consisted of seven cases with Mooren-type peripheral ulcers, three cases with chemical or thermal burns, two cases with vernal keratoconjunctivitis, four cases with cicatricial keratoconjunctivitis, and three cases with sterile ulcers after corneal surgery. Patients consisted of 11 men and 8 women, with a mean age of 51.5 ± 17.9 years (range, 14-77). Only patients who did not respond to conventional therapy were recruited for the study. Lecithinated superoxide dismutase was applied for 2 weeks, and sketches and/or fluorescein slit micrographs were recorded before and at the end of the study. The main outcome measure was decrease in ulcer size. RESULTS: As a group, the average ulcer size relative to the entire cornea decreased from 18.2 ± 15.1% to 10.0 ± 15.0% after 2 weeks (P < .05). A dramatic effect (>90% decrease in ulcer size) was observed in eight cases (100% in six cases), whereas no apparent change was found (<30% decrease in ulcer size) in five cases. The presence of polymorphonucleocytes within the ulcerated tissue was confirmed by brush cytology. CONCLUSION: Lecinthinated superoxide dismutase was effective in decreasing persistent epithelial defect size in a subset of patients with sterile corneal ulcers refractive to conventional therapy. A large-scale clinical investigation is merited.

UR - http://www.scopus.com/inward/record.url?scp=0345352732&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0345352732&partnerID=8YFLogxK

U2 - 10.1016/S0002-9394(02)02151-7

DO - 10.1016/S0002-9394(02)02151-7

M3 - Article

C2 - 12719067

AN - SCOPUS:0345352732

VL - 135

SP - 613

EP - 619

JO - American Journal of Ophthalmology

JF - American Journal of Ophthalmology

SN - 0002-9394

IS - 5

ER -